Clinical Quality Oversight has ended
avatar for Miah Jung, Pharm.D., M.S.

Miah Jung, Pharm.D., M.S.

Acting Branch Chief, Compliance Enforcement Branch, Division of Enforcement and Postmarketing Safety, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research
Miah Jung is a lead pharmacologist in the Compliance Enforcement Branch (CEB), Office of Scientific Investigations, Center for Drug Evaluation and Research (CDER), FDA, and currently the acting Branch Chief in CEB. She has been with FDA for 9 years. In her work, she is responsible for helping to ensure human subject safety and data integrity in clinical studies as part of FDA’s BIMO program. Prior to FDA, she has worked in academia coordinating clinical research studies.

My Speakers Sessions

Tuesday, September 28

11:30am EDT

  • Timezone
  • Filter By Date Clinical Quality Oversight Sep 27 -29, 2021
  • Filter By Type
  • General Session - Live Streamed to Virtual Audience
  • Interactive Workshop - In-Person Only
  • Networking!
  • Track A - In-Person Only
  • Track B - In-Person Only